Blood test may allow safer, lighter chemo for hodgkin lymphoma patients

NCT ID NCT06745076

First seen Nov 01, 2025 · Last updated Apr 28, 2026 · Updated 25 times

Summary

This study tests whether a simple blood test that measures tumor DNA can help doctors safely reduce the amount of chemotherapy for people with advanced Hodgkin lymphoma. About 125 participants will receive either fewer or standard chemotherapy cycles based on their blood test results. The goal is to maintain treatment effectiveness while lowering side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CLASSIC HODGKIN LYMPHOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • City of Hope

    NOT_YET_RECRUITING

    Irvine, California, 92618, United States

    Contact

  • Dana-Farber Cancer Institute

    NOT_YET_RECRUITING

    Boston, Massachusetts, 02215, United States

    Contact

  • Fred Hutch/University of Washington Cancer Consortium

    RECRUITING

    Seattle, Washington, 98109, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Memorial Sloan Kettering Cancer Center

    RECRUITING

    New York, New York, 10065, United States

    Contact

  • Washington University in St. Louis

    RECRUITING

    St Louis, Missouri, 63110, United States

    Contact

Conditions

Explore the condition pages connected to this study.